Want to see GPCR full AI Analyst Report?
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Income Statement
Structure Therapeutics, Inc. Sponsored ADR Income Statement
Last quarter (Q2 2026), Structure Therapeutics, Inc. Sponsored ADR's total revenue was $0.00. In Q2, Structure Therapeutics, Inc. Sponsored ADR's net income was $-106.16M. See Structure Therapeutics, Inc. Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -3.90M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 283.67M | $ 158.23M | $ 102.78M | $ 52.56M | $ 37.70M | |
| Depreciation and Amortization | $ 1.33M | $ 992.00K | $ 295.00K | $ 277.00K | $ 72.00K |
| $ -139.35M | $ -121.22M | $ -75.70M | $ -51.03M | $ -37.62M | |
| $ -287.57M | $ -158.23M | $ -102.78M | $ -52.56M | $ -37.70M | |
| $ 146.51M | $ 36.01M | $ 13.39M | $ 1.26M | $ -122.00K | |
| $ -140.69M | $ -122.22M | $ -89.38M | $ -51.30M | $ -37.82M | |
| $ -141.20M | $ -122.53M | $ -89.62M | $ -51.32M | $ -40.01M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.40 | $ -2.34 | $ -2.43 | $ -1.44 | $ -1.20 |
| Diluted EPS | $ -2.40 | $ -2.34 | $ -2.43 | $ -1.44 | $ -1.20 |
| Weighted Average Shares Outstanding | 59.20M | 52.64M | 36.73M | 36.59M | 36.59M |
| Weighted Average Shares Outstanding (Diluted) | 59.20M | 52.64M | 36.73M | 36.59M | 36.59M |
Currency in USD
